Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver
Authors:
Open Access
- 1 January 2005
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 33 (1) , 175-180
Abstract
The molecular pathogenesis of chemically induced hepatocellular neoplasms and hepatoblastomas in the B6C3F1 mouse is unclear but may involve alterations in the β-catenin/Wnt signaling pathway as was recently described for human liver neoplasms. The objectives of this research were to characterize the mutation frequency and spectrum of β-catenin mutations and the intracellular localization of β-catenin protein accumulation in chemically induced hepatoblastomas and hepatocellular neoplasms. In the majority of the hepatoblastomas examined by immunohistochemical methods, both nuclear and cytoplasmic localization of β-catenin protein were detected, whereas in hepatocellular adenomas and carcinomas and normal liver only membrane staining was observed. Genomic DNA was isolated from paraffin sections of each liver tumor. β-catenin exon 2 (corresponds to exon 3 in humans) genetic alterations were identified in the majority of hepatoblastomas from exposed mice. Deletion mutations were identified more frequently than point mutations in hepatoblastomas. Hepatocellular adenomas and carcinomas from treated mice had mutations in exon 2 of the β-catenin gene which ranged from 32–43%, while 10% β-catenin mutations were detected in spontaneous neoplasms. By immunohistochemical methods cyclin D1 was observed in most nuclei of hepatoblastomas and strong expression of cyclin D1 was confirmed by Western analysis regardless of treatment. The cumulative data suggests that β-catenin mutations with upregulation of the β-catenin protein and Wnt signaling most likely increased cyclin D1 expression. Cyclin D1 may provide an advantage during tumor progression of hepatocellular neoplasms and hepatoblastomas. The review will also focus on other genes which are important in mouse and human liver tumors.Keywords
This publication has 58 references indexed in Scilit:
- Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinomaCarcinogenesis, 2004
- Hypermethylation of the p16 Gene and Lack of p16 Expression in HepatoblastomaLaboratory Investigation, 2003
- Overexpression of Orphan G–Protein-Coupled Receptor, Gpr49 , in Human Hepatocellular Carcinomas With β–Catenin MutationsHepatology, 2003
- Genetic alterations in hepatoblastoma and hepatocellular carcinoma: Common and distinctive aspectsMedical and Pediatric Oncology, 2002
- Greater Expression of Transforming Growth Factor α and Proliferating Cell Nuclear Antigen Staining in Mouse Hepatoblastomas Than Hepatocellular Carcinomas Induced by a Diethylnitrosamine-Sodium Phenobarbital RegimenToxicologic Pathology, 2001
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 1997
- Induction of tyrosine phosphorylation and association of β-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluenceOncogene, 1997
- Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastomaThe Journal of Pathology, 1995
- Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chlorideCarcinogenesis, 1993